Human TNF-alpha Protein (E. coli), premium grade

사용자 리뷰
제품 번호/규격
가격
수량
TNA-H4118-20ug
$80.00
TNA-H4118-100ug
$225.00
TNA-H4118-1mg (200ug X 5)
$1435.00
ETA of in-stock products:2 business days
총 항목 수 제품 금액$ 0

제품 세부정보

  • Features and Advantages

    1. Seamless Transition from Preclinical to Clinical: Same cell clone, process, and QC as GMP products.
    2. Enhanced Production Standards: AOF raw materials, pharma-grade excipients, Grade B+A (ISO 5) environment.
    3. Comprehensive Quality Control: Additional strict testing for process impurities, sterility, and mycoplasma.
    4. Cost-Effective Solution: GMP-comparable quality at an economical price for early development.
    5. Risk Mitigation: Enhanced safety through rigorous impurity control and comprehensive testing.
  • Synonyms

    DIF, TNF-alpha, TNFA, TNFSF2, cachexin, cachectin, TNFα

  • Source

    Human TNF-alpha Protein (E. coli), premium grade (TNA-H4118) is expressed from E. coli cells. It contains AA Val 77 - Leu 233 (Accession # P01375-1).

    Predicted N-terminus: Met

    It is produced under our rigorous quality control system that incorporates a comprehensive set of tests including sterility and endotoxin tests. Product performance is carefully validated and tested for compatibility for cell culture use or any other applications in the early preclinical stage. When ready to transition into later clinical phases, we also offer a custom GMP protein service that tailors to your needs. We will work with you to customize and develop a GMP-grade product in accordance with your requests that also meets the requirements for raw and ancillary materials use in cell manufacturing of cell-based therapies.

    Request for sequence
  • Molecular Characterization

    TNF-alpha Structure

    Other Tags and Version Biotin & Other Labeled Version

    This protein carries no "tag".

    The protein has a calculated MW of 17.5 kDa. The protein migrates as 17 kDa±3 kDa under reducing (R) condition, and 16 kDa when calibrated against Star Ribbon Pre-stained Protein Marker under non-reducing (NR) condition (SDS-PAGE).

  • Endotoxin

    Less than 0.01 EU per μg by the LAL method / rFC method.

  • Host Cell Protein

    <0.5 ng/µg of protein tested by ELISA.

  • Host Cell DNA

    <0.02 ng/μg of protein tested by qPCR.

  • Sterility

    Negative

  • Mycoplasma

    Negative

  • Purity

    >95% as determined by SDS-PAGE.

    >95% as determined by SEC-MALS.

  • Formulation

    Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 with trehalose as protectant.

    Contact us for customized product form or formulation.

  • Reconstitution

    Please see Certificate of Analysis for specific instructions.

    For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.

  • Storage

    For long term storage, the product should be stored at lyophilized state at -20°C or lower.

    Please avoid repeated freeze-thaw cycles.

    This product is stable after storage at:

    1. -20°C to -70°C for 24 months in lyophilized state;
    2. -70°C for 3 months under sterile conditions after reconstitution.
  • ACRO Quality Management System

    1. QMS(ISO, GMP)
    2. Quality Advantages
    3. Quality Control Process
  • Quality Description

    ACRO's Research-grade products are suitable for a wide range of cell culture applications, particularly for research use in academic institutions. These products are sterilized by filtration, followed by lyophilization where applicable. Typical specifications include endotoxin levels of <0.01 EU/μg and purities >95%. Biological activity is calibrated against WHO/NIBSC standards when available.
    ACRO's Premium-grade (Pre-GMP) products are characterized by their high quality and enhanced safety profiles, making them ideal for early-stage discovery and manufacturing processes in cell therapy companies. A key advantage is their seamless transition to corresponding GMP-grade versions. Biological activity is calibrated against WHO/NIBSC standards when available. Typical specifications include endotoxin levels of <0.01 EU/μg and purities >95%. In addition, rigorous testing is conducted to ensure the absence of mycoplasma, HCD, and HCP, thereby guaranteeing product safety.

고객님도 확인한 상품

데이터 표시

  • SDS-PAGE

    TNF-alpha SDS-PAGE

    Human TNF-alpha Protein (E. coli), premium grade on SDS-PAGE under reducing (R) and non-reducing (NR) conditions. The gel was stained with Coomassie Blue. The purity of the protein is greater than 95% (With Star Ribbon Pre-stained Protein Marker).

  • SEC-MALS

    TNF-alpha SEC-MALS

    The purity of Human TNF-alpha Protein (E. coli), premium grade (Cat. No. TNA-H4118) is more than 95% and the molecular weight of this protein is around 45-60 kDa verified by SEC-MALS.

    Report
  • Bioactivity-CELL BASE

     TNF-alpha CELL

    Human TNF-alpha Protein (E. coli), premium grade (Cat. No. TNA-H4118) induces cytotoxicity effect on the WEHI-13VAR cells in the presence of the metabolic inhibitor actinomycin D. The specific activity of Human TNF-alpha, premium grade is > 2.00 x 10^7 IU/mg , which is calibrated against human TNF-alpha WHO International Standard (NIBSC code: 12/154) (QC tested).

    Protocol
  • Bioactivity-ELISA

     TNF-alpha ELISA

    Immobilized Human TNF-alpha Protein (E. coli), premium grade (Cat. No. TNA-H4118) at 1 μg/mL (100 μL/well) can bind Humira with a linear range of 0.06-2 ng/mL (QC tested).

    Protocol

사용자 리뷰
댓글 남기기

배경 소개

Tumor necrosis factor alpha (TNFα) is a cytokine produced primarily by monocytes and macrophages. It is found in synovial cells and macrophages in the tissues.The primary role of TNFα is in the regulation of immune cells. TNFα is able to induce apoptotic cell death, to induce inflammation, and to inhibit tumorigenesis and viral replication. Dysregulation of TNFα production has been implicated in a variety of human diseases, including major depression, Alzheimers disease and cancer. Recombinant TNFα is used as an immunostimulant under the INN tasonermin. TNFα can be produced ectopically in the setting of malignancy and parallels parathyroid hormone both in causing secondary hypercalcemia and in the cancers with which excessive production is associated.

프론티어 진행

 
의약품 개발 진행
  • 영어 이름:

    Tumor necrosis factor α

  • 카테고리:

  • 상장 의약품 수:

    68 상세

  • 임상 의약품 수:

    74 상세

  • 최고 개발 단계:

    Approved

연락하기
신약 후보물질 라이선싱
더 많이 알아보기
  • 기본 제품 정보
  • 제품 세부정보
  • 고객님도 확인한 상품
  • 데이터 표시
  • 사용자 리뷰
  • 배경
문의하기

전화
글로벌: +1 800-810-0816 (무료)
아시아태평양: +86 400-682-2521

주소 서울특별시 송파구 법원로11길 11, 제3층 제비-314,315호